[Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis].
作者信息
Sabliński T, Wasik M A, Tilney N L, Kupiec-Wegliński J W
机构信息
Surgical Research Laboratory, Harvard Medical School, Boston, Massachusetts.
出版信息
Postepy Hig Med Dosw. 1992;46(3):275-85.
PMID:1293580
Abstract
摘要
相似文献
1
[Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis].
Postepy Hig Med Dosw. 1992;46(3):275-85.
3
Interleukin-2 receptor-targeted immune therapy.
Immunol Ser. 1993;59:295-318.
4
Immunomodulation by interleukin-2 receptor targeted therapy.
Natl Med J India. 1994 Mar-Apr;7(2):67-70.
5
6
The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.多链白细胞介素-2受体：接受同种异体移植患者免疫治疗的靶点。
Am J Kidney Dis. 1989 Nov;14(5 Suppl 2):45-53.
7
Development of an immunocytokine, IL-2-183B2scFv, for targeted immunotherapy of ovarian cancer.
Gynecol Oncol. 2006 Dec;103(3):848-52. doi: 10.1016/j.ygyno.2006.05.016. Epub 2006 Jun 23.
8
T cell targeted immunotherapy for autoimmune disease.针对自身免疫性疾病的T细胞靶向免疫疗法。
Autoimmunity. 2005 Dec;38(8):577-96. doi: 10.1080/08916930500418136.
9
[Effects of immunotherapy with anti-L3T4 monoclonal antibody on autoimmune cardiomyopathy: experiment with mice].[抗L3T4单克隆抗体免疫疗法对自身免疫性心肌病的影响：小鼠实验]
Zhonghua Yi Xue Za Zhi. 2005 Dec 14;85(47):3346-9.
10
Which immunological parameters are clinically essential to monitor IL-2 cancer immunotherapy?监测白细胞介素-2癌症免疫疗法时，哪些免疫学参数在临床上至关重要？
J Biol Regul Homeost Agents. 1999 Apr-Jun;13(2):110-4.
Zotero 插件